View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Deals Analysis
February 27, 2022

North America’s medical devices industry saw a drop of 7.48% in deal activity during January 2022

By Nikitha Ladda

North America’s medical devices industry saw a drop of 7.48% in deal activity during January 2022, when compared with the last 12-month average, led by Owens & Minor’s $1.6bn acquisition of Apria , according to GlobalData’s deals database.

  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.

 

A total of 99 medical devices industry deals worth $4.7bn were announced for the region in January 2022, against the 12-month average of 107 deals.

Of all the deal types, venture financing saw most activity in January 2022 with 57 transactions, representing a 57.6% share for the region.

In second place was M&A with 33 deals, followed by private equity deals with nine transactions, respectively capturing a 33.3% and 9.1% share of the overall deal activity for the month.

In terms of value of deals, M&A was the leading category in North America’s medical devices industry with $3.27bn, while venture financing and private equity deals totalled $1.17bn and $250m, respectively.

North America medical devices industry deals in January 2022: Top deals

The top five medical devices deals accounted for 67.4% of the overall value during January 2022.

The combined value of the top five medical devices deals stood at $3.16bn, against the overall value of $4.7bn recorded for the month.

The top five medical devices industry deals of January 2022 tracked by GlobalData were:

1) Owens & Minor $1.6bn acquisition deal with Apria

2) The $623m acquisition of GeneDX by Sema4 OpCo

3) ConvaTec Group $450m acquisition deal with Triad Life Sciences

4) The $250m private equity of Fluidigm by Casdin Capital and Viking Global Investors

5) Maravai LifeSciences Holdings $240m acquisition deal with MyChem

Related Companies

Verdict deals analysis methodology

This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage.

GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.

More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.

Topics in this article:
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network